Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio
Site News
Contact
Market:

Foghorn Therapeutics Inc (FHTX)

Foghorn Therapeutics Inc (FHTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Flagship Pioneering Announces the Merger of Two Leading Programmable Medicine Platforms to Form Sail Biomedicines PR Newswire - Thu Oct 19, 2023

/PRNewswire/ -- Flagship Pioneering today announced the combination of Laronde and Senda Biosciences to launch Sail Biomedicines, a company pioneering the...

DNLI : 24.77 (+3.68%)
FHTX : 8.01 (+6.66%)
MRNA : 82.44 (+1.73%)
OMGA : 1.5500 (+1.97%)
SANA : 5.84 (+2.28%)
MCRB : 0.8707 (+1.24%)
Flagship Pioneering Appoints John Lepore as CEO-Partner and CEO of ProFound Therapeutics PR Newswire - Mon Oct 2, 2023

/PRNewswire/ -- Flagship Pioneering, the bioplatform innovation company, and ProFound™ Therapeutics, a company pioneering the discovery of a vastly expanded...

DNLI : 24.77 (+3.68%)
FHTX : 8.01 (+6.66%)
MRNA : 82.44 (+1.73%)
OMGA : 1.5500 (+1.97%)
SANA : 5.84 (+2.28%)
MCRB : 0.8707 (+1.24%)
Flagship Pioneering Named to Fortune's 2023 "Change the World" List PR Newswire - Wed Sep 27, 2023

/PRNewswire/ -- Flagship Pioneering today announced it has been named to FORTUNE's 2023 "Change the World" list, an annual global ranking of companies that...

DNLI : 24.77 (+3.68%)
FHTX : 8.01 (+6.66%)
MRNA : 82.44 (+1.73%)
OMGA : 1.5500 (+1.97%)
SANA : 5.84 (+2.28%)
MCRB : 0.8707 (+1.24%)
Flagship Pioneering Announces Appointment of Amanda Kay as Chief Business Development Officer PR Newswire - Mon Sep 11, 2023

/PRNewswire/ -- Flagship Pioneering, the bioplatform innovation company, announced today the appointment of Amanda Kay as Senior Partner and Chief Business...

DNLI : 24.77 (+3.68%)
FHTX : 8.01 (+6.66%)
MRNA : 82.44 (+1.73%)
OMGA : 1.5500 (+1.97%)
SANA : 5.84 (+2.28%)
MCRB : 0.8707 (+1.24%)
Flagship Pioneering Announces Appointment of David Khougazian as Growth Partner PR Newswire - Tue Aug 29, 2023

/PRNewswire/ -- Flagship Pioneering, the bioplatform innovation company, announced today that pharma and healthcare leader David Khougazian is joining as...

DNLI : 24.77 (+3.68%)
FHTX : 8.01 (+6.66%)
MRNA : 82.44 (+1.73%)
OMGA : 1.5500 (+1.97%)
SANA : 5.84 (+2.28%)
MCRB : 0.8707 (+1.24%)
Flagship Pioneering Appoints Jason Gardner as CEO-Partner and CEO of Ampersand Biomedicines PR Newswire - Mon Aug 14, 2023

/PRNewswire/ -- Flagship Pioneering, the bioplatform innovation company, and Ampersand Biomedicines, a company programming smarter medicines that act...

DNLI : 24.77 (+3.68%)
FHTX : 8.01 (+6.66%)
MRNA : 82.44 (+1.73%)
OMGA : 1.5500 (+1.97%)
SANA : 5.84 (+2.28%)
MCRB : 0.8707 (+1.24%)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Foghorn Therapeutics Inc. - FHTX PR Newswire - Wed May 10, 2023

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Foghorn Therapeutics Inc. ("Foghorn" or the "Company") (NASDAQ: FHTX). Such...

FHTX : 8.01 (+6.66%)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Foghorn Therapeutics Inc. - FHTX PR Newswire - Tue May 2, 2023

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Foghorn Therapeutics Inc. ("Foghorn" or the "Company") (NASDAQ: FHTX). Such...

FHTX : 8.01 (+6.66%)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Foghorn Therapeutics Inc. - FHTX PR Newswire - Wed Apr 26, 2023

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Foghorn Therapeutics Inc. ("Foghorn" or the "Company") (NASDAQ: FHTX). Such...

FHTX : 8.01 (+6.66%)
Cellarity Strengthens Executive Leadership Team Business Wire - Tue Apr 11, 2023

Cellarity , a life sciences company founded by Flagship Pioneering to transform the way medicines are discovered, announced today the appointments of John Leaman, M.D., M.B.A., as Chief Financial Officer...

IMPL : 0.0400 (-27.27%)
SELB : 0.8812 (-8.00%)
MDGN : 5.57 (+3.15%)
DNLI : 24.77 (+3.68%)
EVLO : 0.0001 (unch)
FHTX : 8.01 (+6.66%)
MRNA : 82.44 (+1.73%)
OMGA : 1.5500 (+1.97%)
SANA : 5.84 (+2.28%)
MCRB : 0.8707 (+1.24%)

Barchart Exclusives

MSFT vs. ORCL: Which AI Software Stock is a Better Buy? Barchart - Sat Aug 24, 10:30AM CDT
Microsoft and Oracle have been leaders in developing market-leading AI software. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot